Protective role of IL-6 in vascular remodeling in schistosoma pulmonary hypertension

American Journal of Respiratory Cell and Molecular Biology

Volumn 49, Issue 6, 2013, Pages 951-959

  Graham, Brian B ^a,b   Chabon, Jacob ^a   Kumar, Rahul ^a   Kolosionek, Ewa ^b   Gebreab, Liya ^a   Debella, Elias ^a   Edwards, Michael ^a   Diener, Katrina ^a   Shade, Ted ^a   Bifeng, Gao ^a   Bandeira, Angela ^c   Butrous, Ghazwan ^b,d   Jones, Kenneth ^a   Geraci, Mark ^a,b   Tuder, Rubin M ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Gene expression profiling; IL 6; Pulmonary hypertension; Schistosomiasis

Indexed keywords

4 [[(4 METHYLPHENYL)SULFONYLOXY]ACETAMIDO]SALICYLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NUCLEAR FACTOR OF ACTIVATED T CELLS C2; STAT3 PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEART CATHETERIZATION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; PULMONARY VASCULAR REMODELING; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; TUNICA MEDIA; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; HYPERTENSION, PULMONARY; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NFATC TRANSCRIPTION FACTORS; PULMONARY ARTERY; RNA, MESSENGER; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84886102085     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0532OC     Document Type: Article

References (34)

1. Chitsulo L, Loverde P, Engels D. Schistosomiasis. Nat Rev Microbiol 2004;2:12-13.
2. De Cleva R, Herman P, Pugliese V, Zilberstein B, Saad WA, Rodrigues JJ, Laudanna AA. Prevalence of pulmonary hypertension in patients with hepatosplenic Mansonic schistosomiasis: prospective study. Hepatogastroenterology 2003;50:2028-2030.
3. Graham BB, Bandeira AP, Morrell NW, Butrous G, Tuder RM. Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 2010;137:20S-29S.
4. Lapa M, Dias B, Jardim C, Fernandes CJ, Dourado PM, Figueiredo M, Farias A, Tsutsui J, Terra-Filho M, Humbert M, et al. Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 2009;119:1518-1523.
5. Tuder RM. Pathology of pulmonary arterial hypertension. Semin Respir Crit Care Med 2009;30:376-385.
6. Dorfmiiller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358-363.
7. Vergadi E, Chang MS, Lee C, Liang OD, Liu X, Fernandez-Gonzalez A, Mitsialis SA, Kourembanas S. Early macrophage recruitment and alternative activation are critical for the later development of hypoxiainduced pulmonary hypertension. Circulation 2011;123:1986-1995.
8. Graham BB, Mentink-Kane MM, El-Haddad H, Purnell S, Zhang L, Zaiman A, Redente EF, Riches DW, Hassoun PM, Bandeira A, et al. Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling. Am J Pathol 2010;177:1549-1561.
9. Crosby A, Jones FM, Southwood M, Dunne DW, Morrell NW. Praziquantel prevents progression of right ventricular hypertrophy in a mouse model of schistosomiasis. Am J Respir Crit Care Med 2010;181:A4895.
10. Crosby A, Jones FM, Southwood M, Stewart S, Schermuly R, Butrous G, Dunne DW, Morrell NW. Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis. Am J Respir Crit Care Med 2010;181:279-288.
11. Daley E, Emson C, Guignabert C, De Waal Malefyt R, Louten J, Kurup VP, Hogaboam C, Taraseviciene-Stewart L, Voelkel NF, Rabinovitch M, et al. Pulmonary arterial remodeling induced by a Th2 immune response. J Exp Med 2008;205:361-372.
12. Cho WK, Lee CM, Kang MJ, Huang Y, Giordano FJ, Lee PJ, Trow TK, Homer RJ, Sessa WC, Elias JA, et al. IL-13 receptor alpha2-arginase2 pathway mediates IL-13-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2013;304:L112-124.
13. Graham BB, Chabon J, Kolosionek E, Edwards M, Bandeira A, Geraci M, Butrous G, Tuder R. Whole lung transcriptome analysis of a model of schistosomiasis-associated pulmonary hypertension [abstract]. Am J Respir Crit Care Med 2012;185:A3433.
14. Bauer MJ, Cox AJ, Evers DJ. ELANDv2 - fast gapped read mapping for illumina reads. In: Proceeding of the 18th annual conference on intelligent systems for molecular biology. La Jolla: International Society for Computational Biology; 2010. p. J04.
15. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, Van Baren MJ, Salzberg SL, Wold BJ, Pachter L. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010;28:511-515.
16. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-seq. Bioinformatics 2009;25:1105-1111.
17. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol 2009;10:R25.
18. Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009;10:165-177.
19. Recklies AD, Ling H, White C, Bernier SM. Inflammatory cytokines induce production of Chi3l1 by articular chondrocytes. J Biol Chem 2005;280:41213- 41221.
20. Bonnet S, Rochefort G, Sutendra G, Archer SL, Haromy A, Webster L, Hashimoto K, Bonnet SN, Michelakis ED. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted Proc Natl Acad Sci USA 2007;104:11418-11423.
21. Courboulin A, Paulin R, Giguère NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Côté J, et al. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 2011;208:535-548.
22. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009;104:236-244.
23. Chen JW, Murphy TL, Willingham MC, Pastan I, August JT. Identification of two lysosomal membrane glycoproteins. J Cell Biol 1985;101:85-95.
24. De Jesus AR, Silva A, Santana LB, Magalhães A, De Jesus AA, De Almeida RP, Rêgo MA, Burattini MN, Pearce EJ, Carvalho EM. Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. J Infect Dis 2002;185:98-105.
25. Johnson AW, Kinzenbaw DA, Modrick ML, Faraci FM. Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension. Hypertension 2013;61:437-442.
26. Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, Luo L, Zhang XH, Xiao J, Alekseyev YO, et al. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-seq. Cancer Prev Res (Phila) 2011;4:803-817.
27. Garber M, Grabherr MG, Guttman M, Trapnell C Computational methods for transcriptome annotation and quantification using RNA-seq. Nat Methods 2011;8:469-477.
28. Savale L, Tu L, Rideau D, Izziki M, Maitre B, Adnot S, Eddahibi S. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res 2009;10:6.
29. Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G, Russo MA, Gu Y, Dalton N, Chung C, et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 2002;99:12333-12338.
30. Diehl S, Rincón M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002;39:531-536.
31. Ganeshan K, Bryce PJ. Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β. J Immunol 2012;188:594-603.
32. Kugathasan L, Ray JB, Deng Y, Rezaei E, Dumont DJ, Stewart DJ. The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice. J Exp Med 2009;206:2221-2234.
33. McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry G, Bonnet S, Puttagunta L, Michelakis ED. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 2005;115:1479-1491.
34. Cunningham J, Basu K, Tavendale R, Palmer CN, Smith H, Mukhopadhyay S. The Chi3l1 rs4950928 polymorphism is associated with asthma-related hospital admissions in children and young adults. Ann Allergy Asthma Immunol 2011;106:381-386.